Please login to the form below

Not currently logged in
Email:
Password:

AZ to sell Astra Tech for $1.8bn

AstraZeneca is to sell Sweden-based dental and devices business Astra Tech to Dentsply for $1.8bn

AstraZeneca (AZ) is to sell Sweden-based dental and devices business Astra Tech to Dentsply for $1.8bn.

Dentsply, a US-based dental equipment maker, is anticipated to complete the acquisition in the second half of 2011.

Astra Tech consists of a dental division, focusing on the research, development, manufacturing and marketing of dental implants; and a healthcare division, focusing on medical devices for use primarily in urology and surgery.

Worldwide revenue for Astra Tech was recorded as $535m for 2010.

"Following a comprehensive strategic review, we believe this transaction represents an excellent outcome for AstraZeneca shareholders," said David Brennan, CEO, AZ. "The high degree of interest and the competitive nature of this process is evidence of the value that the employees of Astra Tech have built in the marketplace."

22nd June 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
WiredRelease

WiredRelease is an organization established in 2019, intended to offer online press release distribution service. Here companies can promote just...

Latest intelligence

White Paper for download - Explaining the price of your product
In this white paper, he breaks down the pricing options available to you, shares stories from his extensive experiences, and talks you through how to better define your pricing, step-by-step....
OPEN Health expands offering with the launch of a new Learning & Development specialist team
Enhanced expertise to deliver impactful internal training programmes for healthcare clients...
Figure 1 Clarivate
The changing nature of approvals – what does the future hold?
The 2019 CMR International Pharmaceutical R&D Factbook...

Infographics